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Abstract
Background: The complex trait of prepulse inhibition (PPI) is a sensory gating measure related to schizophrenia and can be
measured in mice. Large-scale public repositories of inbred mouse strain genotypes and phenotypes such as PPI can be
used to detect Quantitative Trait Loci (QTLs) in silico. However, the method has been criticized for issues including
insufficient number of strains, not controlling for false discoveries, the complex haplotype structure of inbred mice, and
failing to account for genotypic and phenotypic subgroups.
Methodology/Principal Findings: We have implemented a method that addresses these issues by incorporating
phylogenetic analyses, multilevel regression with mixed effects, and false discovery rate (FDR) control. A genome-wide scan
for PPI was conducted using over 17,000 single nucleotide polymorphisms (SNPs) in 37 strains phenotyped. Eighty-nine
SNPs were significant at a false discovery rate (FDR) of 5%. After accounting for long-range linkage disequilibrium, we found
3 independent QTLs located on murine chromosomes 1 and 13. One of the PPI positives corresponds to a region of human
chromosome 6p which includes DTNBP1, a gene implicated in schizophrenia. Another region includes the gene Tsn which
alters PPI when knocked out. These genes also appear to have correlated expression with PPI.
Conclusions/Significance: These results support the usefulness of using an improved in silico mapping method to identify
QTLs for complex traits such as PPI which can be then be used for to help identify loci influencing schizophrenia in humans.
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Introduction
Traditional approaches for mapping quantitative trait loci
(QTLs) in mice usually involve crossing two strains that differ in a
trait of interest, followed by phenotyping and genotyping a large
number of the resulting progeny. The chromosomal regions
identified with this approach are large, typically 20–40 cM [1],
and further work is therefore needed to pinpoint the specific
gene(s) and causal mutation(s) responsible for the QTL effect. The
whole process is expensive and may require many years of study.
However, databases have recently been created that contain data
from large scale genotyping projects involving many common
inbred mouse strains. Combining this data with phenotypic
information on the same strains creates the opportunity to map
QTLs ‘‘in silico’’ [2]. Since all mice from an inbred strain are
genetically identical and homozygous, genotyping need only occur
once and their haplotypes can be derived unambiguously from
their genotypes. Once the phenotype is known one can 1) group
the mice from strains with similar genotypes and then 2) test for
the phenotypic differences between the mice with the different
genotypes. By repeating this for a genome-wide panel of markers,
a whole-genome scan can be performed in silico for detecting
haplotypes that harbor variants influencing the trait.
There seems little doubt that in silico scans are useful to detect
highly penetrant mutations [3–5] and a number of successful
examples can be found in the literature [6–8]. However, the utility
of this method for finding QTLs for complex traits is more
controversial. Some criticisms involve the specific execution of the
method, such as the use of a very small number of inbred strains,
or insufficient control of false discoveries due to multiple testing
problems [9,10]. In principle, these criticisms can be easily
addressed, by increasing the number of strains in the analysis or
using new and more powerful methods to control false discoveries
[11]. Other criticisms may be more fundamental, such as
difficulties arising from the complex haplotype structure of inbred
mice or the risk of false discoveries due to the presence of
genotypic and phenotypic subgroups of mouse strains [12]. Other
fast and cost-effective in silico methods exist, such as using a panel
of recombinant inbred lines derived from only 2 parental inbred
lines [13–15] that are much less affected by these phenomena.
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However, it may be premature to discard in silico mapping of
QTLs for complex traits using common inbred strains. The
method is new and at least some of the criticisms may be addressed
by further developing our analytical strategies.
For example, the lack of randomness in breeding histories of
inbred strains in combination with the fact that subgroups may
also differ phenotypically can create spurious associations. That is,
all genetic differences between the subgroups will tend to be
associated with the phenotype and there would be no possibility to
distinguish true and spurious associations. In human studies, an
analogous issue is population stratification, which is a great
concern. In samples containing subjects with multipleancestries,
this must be addressed using appropriate statistical controls [16].
Otherwise, tens of thousands or markers will appear significant in
the genome-wise association studies using up to one million genetic
markers. Approaches to control for stratification include using of
self report of ancestry or genetically derived principle components
in the analysis. For studies using inbred mouse lines, a cladogram
which is a hierarchical grouping based on phylogenetic analysis of
strain relatedness can be created to subdivide inbred strains into
more genetically homogenous subgroups. By testing whether or
not haplotypes are associated with the phenotypes within these
cladistic subgroups which are akin to branches in the tree, we
reduce the risk of false positives. This is because genetic variation is
now related to deviations from the subgroup mean, so that
phenotypic differences between strains are no longer necessarily
associated with genetic differences between strains.
If we assume that the methodological problems can be
addressed, in silico scans do have a number of potential advantages.
First, since the average ancestral segment length among classical
inbred strains has been estimated to be 1.0–1.5 megabases (Mb) in
size, the resolution is relatively good in comparison to traditional
QTL mapping methods. Second, the costs for many common
inbred mouse lines are relatively low in comparison to recombi-
nant inbred lines. Third, the amount of phenotypic and genotypic
information on common inbred strains is increasing rapidly.
Examples of freely available repositories such as the Mouse
Phenome Database (MPD - [17]) and WebQTL continue to grow.
These resources include not only strain phenotypes but also
genotypes from large scale projects that have recently been
completed (http://www.well.ox.ac.uk/mouse/INBREDS/) and
others in progress. The availability of all this information has the
potential to produce novel results with the only cost being analysis
time. Finally, the presence of multiple founder lines as well as wild
derived inbred strains can be advantageous. First, there is more
genetic and phenotypic diversity when many strains are used.
Therefore the potential to detect more causal variants is increased.
In mapping using F2 crosses of only two strains, much of the
variation that is present in the population from which the two lines
were drawn is excluded and not detectable. Although the use of
multiple founder lines introduces more alleles and decreases
relative effect size, the process is much more analogous to human
association mapping. Therefore, the results may also be more
generalizable across lines and perhaps species. This is important
because the generally accepted eventual goal of using model
organisms is to generalize the knowledge to humans. Results such
as these can be used in cross species data integration[18] which
can lead to the identification of novel associations in humans[19].
Although clearly of potential utility, in silico scans alone will
probably not be able to identify the actual causal variants. Instead
they may better be viewed as part of a fast and inexpensive method
to identify and prioritize complex-trait candidate genes without
requiring the construction of (sub)congenic mouse strains [8]. The
likely outcome of an in silico scan is a number of small
chromosomal regions that contain causal variants. Existing
databases can then be used to identify the candidate genes in
the regions and look for corroborating evidence. Furthermore,
other ‘‘omic’’ platforms (e.g. expression arrays) could be use to
further reduce the list of candidate genes and refine the region [20]
In this study we performed an in silico scan using phenotypic
data generated by Willott and colleagues [21] for the complex trait
prepulse inhibition (PPI), a sensory gating measure thought to be
related to schizophrenia. A recent review cited 13 different studies
that found PPI deficits in schizophrenic patients [22]. PPI is also
variable and heritable in humans with and without psychiatric
diagnoses [23,24] and in model organisms. Deficits in PPI can be
induced pharmacologically and reversed with antipsychotics [25].
PPI has also been the subject of phenotypic characteriza-
tion[26,27] and QTL mapping efforts in rodents [28–35]. QTLs
identified in silico were compared against evidence from a variety of
sources including previous mouse PPI QTLs, meta-analysis of
human schizophrenia genome scans, and microarray experiments
in an attempt to find convergent or consistent patterns of evidence.
Results
In silico scan
Our base model was a 2-level model where mice were nested in
strains with sex and clade membership included as covariates.
SNPs were added to this base model and tests performed to
examine whether this significantly improved model fit. Figure 1
plots the p-values for all SNPs across the mouse genome. The
conservative ‘‘lowest slope’’ method (Hsueh et al., 2003) estimated
the proportion of true null hypotheses to be 0.991017. Using this
estimate, we found 89 significant SNPs when the FDR was
controlled at the 0.05 level. Because of the large number of tests,
this means that the estimated proportion of false discoveries
among the 89 significant tests was 5%. The number of significant
SNPs dropped noticeably from 89 to 20 when the FDR was
controlled at the 0.045 rather than 0.05 level, which corresponded
with a threshold p-value of 5.0e-5. We focused these SNPs in order
to have tractable number of results to interpret. The full list of
results satisfying a FDR of 5% are contained in Table S1.
The top 20 significant SNPs map to 8 regions with 5 isolated
SNPs, 2 clusters of 3 to 4 SNPs, and one cluster of 8 SNPs. Details
are contained in Table 1. Examination of linkage disequilibrium
(LD) using r2 between the top 20 markers revealed meaningful LD
(,1% for genome-wide marker-marker r2) between many of the
markers pairs including those on different chromosomes. Table 2
contains these results and shows that within the set of 20 there are
three sets of mirror markers containing 7, 3, and 2 markers.
However, they all contain at least one marker from the cluster of
positive markers on chromosome 1 between 115.9–118.9 Mb.
SNP and gene positions are based on the May 2004 assembly
(Build33) of the mouse genome at the UCSC Genome Browser
[36]. After examining the r2 for each of the top 20 markers with
every other marker in the genome and the 2 marker association
results within each mirror (data not shown), we believe that the
most parsimonious explanation of the pattern of results is that the
cluster on chromosome 1 is origin of the mirrors. After accounting
for mirrors that reflect the cluster of significant markers on
chromosome 1, only 2 additional independent signals remain and
are rs3698264 (chromosome 1, 79.9 Mb, index 575) and
rs3724682 (chromosome 13, 46.8 Mb, index 12594).
Support for results
The identified QTLs were compared with a variety of sources
including previous mouse PPI QTLs, meta-analysis of human
PPI In Silico Scan
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schizophrenia genome scans, and microarray experiments. The
mouse/human chain track within the genome browser was used to
compare regions homologous between mouse and human
genomes [37,38].
Replication of previous mouse QTLs
There are previous studies attempting to map QTLs for PPI in
mice. Joober and colleagues provisionally mapped PPI QTLs
using recombinant congenic strains based on inbred lines C57BL/
6J and A/J [29]. For auditory PPI, they initially reported 7 QTLs
common across all acoustic intensities studied and an additional 25
loci linked to at least one acoustic intensity for a total of 32
provisional loci. However, the analytical methodology was
criticized [39] and a more appropriate analysis showed a more
modest list of significant loci which included chromosomes 2, 3, 5,
7, 11, and 16 [40]. The results from chromosome 16 have been
investigated further by Petryshen [31] who performed QTL
mapping by intercrossing chromosome substitution strains (CSS).
The parental CSSs carried an A/J chromosome 16 on a C57BL/
6J background. The 2 initial QTL intervals described by Joober
and colleagues on 16 were confirmed and the interval narrowed.
We do not believe our results robustly replicate any reported QTL
on 16. Joober et al. have since expanded upon their auditory work
using tactile PPI which didn’t replicate their auditory PPI
results[35].
PPI QTL mapping has also been performed using an F2 cross of
C57BL/6 and C3H/He lines and identified a PPI locus at the
Fabp7 gene [33] on chromosome 10. We did not detect any
significant markers in the region of Fabp7. Watanabe et al. also
reported provisional QTLs on chromosomes 1, 3, 7, 11, and 13.
However, the sizes of the linked regions were not reported and
therefore any overlap with loci on chromosomes 1, 11, and 13 in
the current study could not be compared directly.
Finally, Hitzemann and colleagues have attempted to map PPI
QTLs using selectively bred lines from a heterogeneous stock
derived from four inbred lines including C57BL/6J, DBA/2J,
BALB/cJ and LP/J[34]. This effort is the most analogous to the
current study due to the use of multiple founder lines. However,
the study was directed at previously implicated chromosomes 3,
11, and 16. The signal we detected at rs6299418 on chromosome
11 is consistent with the interval reported by Hitzemann et al [34].
Loci for human schizophrenia
We examined if the three independent in silico mouse PPI QTLs
results mapped to the regions implicated by the [41] meta-analysis
of human schizophrenia genome scans. The meta-analysis is a
large study using 20 linkage scans with a total of 1,208 pedigrees
and 2,945 affecteds. In the study, the genome was divided into 120
separate 30-cM bins. The top ten bins represent 8 different regions
comprising 300 cM or ,8% of the human genome. Four of the
eight homologous mouse regions contained at least 1 significant
SNP in our scan, when the FDR was controlled at the 0.05 level,
including the signals on chromosomes 1 and 13.
On chromosome 1 in the area surrounding marker rs3674655
(p-value 8.1461027, index814), which is homologous to human
2q14, the LD pattern shown in Figure 2 is irregular. There are no
obvious places to define a boundary, even when attempting to use
an arbitrary standard such as r2 above a whole genome cut off of
one percentile. By examining individual haplotypes (data not
shown), we estimate the core of the association signal extends at
least 3 megabases (Mb) from rs13476069 (index 802, 115.9 Mb) to
rs13476078 (index825, 118.9 Mb) but may extend as much as
Figure 1. Plot of p-values from PPI scan across mouse genome with corresponding FDR thresholds.
doi:10.1371/journal.pone.0005246.g001
PPI In Silico Scan
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5.7 Mb from mCV23695506 (index792, 114.4 Mb) to rs3696498
(index 833, 120.1 Mb).
The 5.7 Mb interval includes genes Tsn, Inhbb, Ralb, Epb4.1l5,
Ptpn4, Sctr, Dbi, and Steap3, several of which are good functional
candidates for PPI and schizophrenia. Ptpn4 (the protein tyrosine
phosphatase, non-receptor type 4) interacts with glutamate
receptors, Grin2a and Grid2. Glutamate receptors are good
candidates for schizophrenia and GRIN2A has been the subject
of human schizophrenia association studies [42–44]. Sctr, the
secretin receptor gene, is also a good candidate since phencycli-
dine-induced impairment of PPI is partially reversed by secretin
[45]. Finally, Translin (Tsn) is a gene known to alter PPI when
knocked out in mice [46]. In addition, the TSN protein (also
designated TB-RBP) interacts functionally with translin-associated
factor X (TSNAX or TRAX) [47]. The human TRAX gene is
adjacent to DISC1, a gene implicated in schizophrenia, and
haplotypes covering both DISC1 and TRAX in humans have been
reported to be associated with schizophrenia [48,49]. Several
DISC1 transcripts contain TRAX sequence including one that
encodes a TRAX/DISC1 fusion protein [50]. Therefore, TSN may
interact with DISC1.
In contrast to the multiple signals and inconsistent LD pattern
seen on chromosome 1, the interval on 13qA5 between
rs6271232–rs6244558 (minimum p-value 4.861025, FDR
,0.045) shown in Figure 3 presents a much more regular pattern
of LD even though the interval is large (,5.4 megabases).
Interestingly, Dtnbp1 sits in the middle of the interval. The human
homolog of this gene has demonstrated multiple highly significant
associations with schizophrenia, [51–60]. Although there is a
region of relatively reduced LD in the middle of the interval, the
markers flanking Dtnbp1 are in LD with the SNPs showing
association at either end. Also mapping to this interval is Cap2.
The human homolog of this gene has been reported to show
altered expression in human schizophrenic brain [61]. This
interval was tentatively implicated by Joober et al. in their study
of mouse PPI [29]. However, it was not one of the six
chromosomes that remained after reanalysis [40].
The results for the third in silico QTL at rs3698264
(chromosome 1, 79.9 Mb, index 575, p-value 0.000034) appeared
to be an isolated signal when only single marker analysis was
considered. However, tests of sliding 2 marker windows showed
additional evidence independent of rs3698264. In the 1 megabase
interval surrounding but not including rs3698264, the p-values
ranged from 0.045 to 0.00083. The most significant 2 marker
result which includes rs3698264 is for rs3698264-rs8253473 (p-
value 5.861027) and defines an 89.5 kilobases (kb) interval
containing part of the secretogranin II (Scg2) gene. Indeed, Scg2
also known as chromogranin C contains rs8253473. This marker
defines the end of the most associated two marker haplotype in the
genome and not just the region nearby. Scg2 is a plausible
candidate for influencing PPI. Phencyclidine (PCP) modulates Scg2
expression in rats [62,63]. Genes responding to PCP are good
candidates for schizophrenia since PCP produces effects similar to
schizophrenia in humans. In model organisms, PCP creates PPI
deficits that can be ameliorated with administration of atypical
antipsychotics [25]. There are also positive human schizophrenia
association studies with chromogranin B which is a closely related
gene [64,65].
PPI and selected gene expression in hippocampus
Selected gene expression information was obtained via
WebQTL. The data was generated by the Hippocampus
Table 1. Chromosomal band, megabase (Mbp) location, and P-value of SNPs that are significant when the FDR is controlled at
0.045 level.
Cluster Marker Index chr Mbp Cytogenetic location p-value
1 rs6404446 140 1 20.994482 1qA4 4.39E-06
1 rs3716569 141 1 21.012714 1qA4 2.21E-06
1 rs4222181 142 1 21.024671 1qA4 3.33E-06
2 rs3698264 575 1 79.865390 1qC4 3.39E-05
3 rs6268443 657 1 93.319361 1qD 4.86E-06
4 rs3022830 802 1 115.928102 1qE2 1.78E-05
4 rs3694226 811 1 117.143094 1qE2 4.39E-06
4 rs3662732 813 1 117.337845 1qE2 1.20E-06
4 rs3674655 814 1 117.379659 1qE2.3 8.14E-07
4 CEL-1_117526378 816 1 117.526378 1qE2 8.14E-07
4 rs6216134 820 1 118.236415 1qE2 1.29E-05
4 rs3719973 824 1 118.834067 1qE2 1.29E-05
4 rs13476078 825 1 118.930213 1qE2 2.67E-05
5 rs6215373 5262 5 42.914749 5qB3 3.27E-05
5 mCV22331571 5265 5 43.271643 5qB3 5.00E-05
5 rs3669254 5266 5 43.347335 5qB3 5.59E-06
5 rs3663092 5270 5 43.668813 5qB3 5.15E-06
6 rs3691954 8102 8 21.206986 8qA2 4.09E-05
7 rs6299418 11098 11 66.784499 11qB3 4.39E-06
8 rs3724682 12594 13 46.810500 13qA5 4.75E-05
Index is the marker order across the genome and is used in subsequent tables and figures instead of marker name.
doi:10.1371/journal.pone.0005246.t001
PPI In Silico Scan
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Consortium on M430 arrays using hippocampus tissue and
analyzed using the RMA method. Data was available for 12 of
the 40 lines with PPI data. We tested for correlation between PPI
and hippocampus expression of candidate genes selected from the
top 3 regions. Due to the small number of lines (n = 12) with both
PPI and expression information, we chose only to test microarray
probesets in a limited number of genes that we had prior evidence
for a relationship to schizophrenia or PPI. These genes were Scg2,
Dtnbp1, Cap2, and Tsn. Details of the results are shown in Table 3.
PPI was significantly correlated with gene expression for one of
two probesets in Cap2 (r =20.6, p-value = 0.039) and approached
significance using at least one probeset in Dtnbp1 (p-value 0.1) and
Tsn (p-value 0.085). We performed exploratory analysis looking for
statistical interactions between gene expression levels and PPI
using linear regression and mixed models. We observed that
different probesets within the same gene such as with Tsn gave
different results. Although this may seem inconsistent, further
examination of the alignment of probes to gene revealed that
different probesets for Tsn aligned to different populations of
alternatively polyadenylated transcripts. Further analysis using
univariate mixed models revealed the same pattern results across
the probesets but with increased significance. A highly significant
interaction was detected between Dtnbp1 and Scg2 (p-val-
ue = 0.00024). Although Tsn (mixed model p-value 0.052) and
Cap2 (mixed model p-value 0.02) are significant when considered
individually and together (mixed model p-value 0.009, based on
2df), they do not contribute significantly in the presence of the
Dtnbp1-Scg2 interaction.
Discussion
We found 89 SNPs that were likely to have real effects on PPI
(FDR,0.05). When we conservatively considered only the top 20
based on FDR and the distinct LD pattern of the inbred mouse
genome, these 20 collapsed into 3 probable distinct independent
regions. These 3 independently associated loci are likely to affect
PPI (FDR 0.045) including a 3 to 6 megabase interval on
chromosome 13 and two separate loci on chromosome 1. Next,
we showed that 2 of these regions correspond to regions implicated
in human linkage studies of schizophrenia. The region on
chromosome 13 that is implicated by both our in silico PPI analyses
and human linkage studies was also implicated in a provisional QTL
mapping study of PPI in mice by Joober et al [29] using
recombinant congenic strains. However, chromosome 13 did not
remain significant when a more appropriate analysis was conduct-
ed[40]. The gene Dtnbp1 is in the middle of this region. This is an
encouraging finding as several association and expression studies
suggest that the human homolog of Dtnbp1 is one of the strongest
candidates for schizophrenia [51–60]. In addition, the human
homolog of another gene in this region, Cap2,is reported to show
altered expression in schizophrenic brain [61].
The region on chromosome 1 that is implicated by both the in
silico PPI analyses and human linkage studies contains the genes
Tsn and Scg2. Tsn is directly implicated in mouse PPI as it is known
to alter PPI when knocked out [46] and Scg2 is PPI candidate due
to multiple lines of evidence [25,62–65]. Finally, we found that
hippocampus expression is at least suggestively significantly related
to PPI for all four genes Dtnbp1, Cap2, Tsn, Scg. Analyses of these
expression data also showed a highly significant relationship
between PPI and a statistical interaction between Dtnbp1 and Scg2.
In sum, results suggest that the in silico mapping of QTLs can be
improved and successfully adapted to help map loci for complex
traits. That is, the obtained results were supported by converging
evidence from a variety of sources including previous mouse PPI
QTLs, meta-analysis of human schizophrenia genome scans, and
microarray experiments. In silico scans have several attractive
properties such as the low costs of the mice, relatively more genetic
variation due to multiple ancestral strains, and public availability
Figure 2. Plot of linkage disequilibrium (LD) around associated SNPs on chromosome 1. The numbers on the axes are the marker index
which is the relative order of the SNPs across the genome and corresponds to the results in Table 1.
doi:10.1371/journal.pone.0005246.g002
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of genotype/phenotype information. This suggests that these scans
can be a valuable addition to our method arsenal for mapping
genetic variation affecting complex traits. Although the resolution
is relatively good in comparison to traditional QTL mapping
methods, the QTLs detected by the in silico methods still spanned
2–4 MB. However, we also demonstrated how public resources
can be used to add weight to findings and identify specific
candidates. As the amount and quality of information in public
data bases increases, we would expect this ability to refine the
location of relevant genetic variation to improve in parallel.
Finally, as the focus in the present study was to demonstrate the
usefulness of the method, we focused on genes and loci for which
there is already a considerable amount of evidence in the
literature. However, this does not mean that the method cannot
generate novel candidates and even in our case we expect that
other previously less studied genes could affect schizophrenia and
are performing association studies to follow up these leads.
Materials and Methods
Sample and measurements
To perform an in silico scan, we first matched PPI data for 37
different strains to 17,757 SNPs contained in the MPD. The 37
phenotyped strains with genotype information were from a study
40 strains and represented 805 individual inbred mice with
approximately 10 animals of each sex per strain [21]. The majority
(,13 k) of the SNP data came from the Wellcome-CTC Mouse
Strain SNP Genotype Set (www.well.ox.ac.uk/rmott/MOUSE/
INBREDS) and the remainder from a variety of other sources
including dbSNP, the Jackson Lab [66], and The Scripps
Research Institute [5]. The PPI variable analyzed was PPI total,
which is a summary measure across three different acoustic startle
frequencies (70 dB at 4, 12, and 20 kHz). Although other PPI
Figure 3. Plot of LD near associated SNPs near DTNBP1 (index12555) and rs3724682 (index12594).
doi:10.1371/journal.pone.0005246.g003
Table 3. Results of correlation (r) and linear regression
(adjusted r2) using gene expression of selected microarray
probes from candidate genes near positive regions from in
silico scan.
Gene Probe r adj r2 p-val
Cap2 1450910 20.14 20.08 0.67
Cap2 1423222 20.60 0.30 0.039
Dtnbp1 1431619 20.50 0.18 0.10
Scg2 1450708 20.47 0.14 0.12
Tsn 1448516 0.52 0.19 0.085
Tsn 1448515 0.40 0.08 0.19
Tsn 1416908 0.20 20.05 0.53
Tsn 1416907 0.20 20.06 0.53
Gene expression microarray analysis method is RMA.
doi:10.1371/journal.pone.0005246.t003
PPI In Silico Scan
PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5246
variables were generated by Willott and colleagues, they argue that
PPI total is the best measure for sensory gating. Ambiguous
genotypes and heterozygotes were removed. One hundred
seventy-three markers were found to be named duplicates and
removed. A further 725 markers were removed from analysis
because they were not polymorphic between our 37 selected
strains. This left a total panel of 16,859 SNPs.
Phylogenetic analyses
The lack of randomness in the breeding history of inbred strains
in combination with the fact that strain subgroups may also differ
phenotypically can create spurious associations. Our approach to
minimize such spurious findings mimics ‘‘within family’’ based
analyses often applied in human association studies to avoid
similar problems due to population stratification. By testing
whether a locus within a family is associated with the outcome,
spurious associations are avoided because all family members
come from the same subpopulation. To define ‘‘families’’ of inbred
strains of mice we estimated the phylogenetic relationship for 480
inbred strains of mice using the APE (Analyses of Phylogenetics
and Evolution) extension to the R language (results not shown).
Because an extensive search is impossible with as many as 15 k
SNPs we used the maximum parsimony algorithm that minimizes
the number of steps, or tree length, needed to account for the
differences between strains. The main groupings we observed
replicated those found by Petkov et al. who constructed a ‘‘family
tree’’ for 102 strains using 1,638 SNPs [66]. Each of the 37 strains
used in the current study were assigned to one of 7 possible
phylogenetic subgroups or clades from our cladistic analysis.
Family trees and cladograms are not synonymous since cladistics
has its own set of rules for defining family trees. Therefore, not all
hierarchical arrangements of strains are cladograms since
cladograms reflect similarity and not descent. Details of the strains
used and clade assignment are contained in Table S2.
Mixed/multilevel models
The tests between phenotype and genotype were performed
using multilevel or mixed modeling [67,68]. Multilevel models are
particularly suitable for analyzing samples with a hierarchical or
clustered structure. Clustered data are present here because
multiple animals from the same strain are assessed. The inclusion
of SNPs as well as subgroup membership in multilevel models is
straightforward [69]. Specifically for the current study, let o be an
overall constant, ck the effect of phylogenetic subgroup k, gj the
effect of SNP j, and rijk a residual score of mouse i with genotype j
from subgroup k consisting of the effects of other unlinked loci and
environmental factors. The trait score xijk of mouse i with SNP j
from subgroup k can then be written as: xijk = o+ck+gjk+rijk. The
statistical test will involve effect gjk. Because gjk is the deviation
from the subgroup mean it will only be significant if within the
subgroup SNP j has an effect. Scripts were written and analyses
performed in the R statistical environment. Specifically, the nlme
package was used to perform mixed/multilevel model analysis.
The maximum likelihood (ML) method was used instead of the
default restricted maximum likelihood (REML) to be able to
perform tests for fixed plus random effects in the model. Two times
the difference between log-likelihoods of the model with and
without genetic effect gjk is asymptotically chi-square distributed,
with the difference in estimated parameters of the nested models as
the degrees of freedom. After single marker analyses were
completed, haplotype analyses with multiple markers were
performed to determine risk haplotype and estimate the size of
the associated region.
Control of false discoveries
In our in silico scan, the vast majority of the SNPs will not be
associated with the dependent variables and this creates a
considerable risk of false discoveries. In this article, we control
the so-called false discovery rate [70,71]. Because of the large
number of tests that are performed in this study, we can interpret
the FDR as the proportion of false discoveries to the total
discoveries we would on average introduce into the literature
through this study. Alternatively, FDR can be interpreted as the
probability that a randomly selected discovery from this study is
false [71–73].
An important advantage of the FDR in this context is that it
provides a better balance between finding true effects and
controlling false discoveries compared to more traditional
‘‘family-wise’’ methods that control the probability of finding
one or more false discoveries in the whole study (e.g. the single step
Bonferroni correction). The problem is that family-wise error
methods control exclusively to the risk of even a single false
discovery. Because this risk is high in genome-wide scans, these
studies will be heavily penalized via very small threshold p-values.
As a result power will be low to detect genetic effects.
In addition to its pleasant interpretation, the FDR appears fairly
robust against the effects of correlated tests in general
[11,70,71,74–77] and the correlational structure of linkage
disequilibrium (LD) studies in particular [78,79]. An intuitive
explanation is that these methods use estimates of the ratio of false
to total discoveries in a study. Correlated tests mainly increase the
variance of these estimates. However, the FDR statistics
themselves that are the means of these estimates tend to remain
similar. To avoid that the FDR is controlled too conservatively we
need to estimate the proportion of tests for which the null-
hypothesis is true. For this purpose we used the ‘‘lowest slope’’
method, known to be conservatively biased toward one [80].
Defining the QTL interval
Inbred laboratory mouse strains originated from a mixed but
limited founder population [81]. Although recombination breaks
up chromosomes when they are passed on to the next generation,
the number of generations that occurred before inbreeding was
limited. As a result current inbred mouse strains share extensive
haplotypes from their founder strains, causing LD or associations
among markers that are close to each other on the mouse genome.
Indeed, by typing a large set of SNPs in nine inbred stains, [3]
found that for most of the chromosomal regions few (e.g. two)
different founder haplotypes were observed. Thus, for each of the
significant markers, the QTL interval needs to be defined. LD can
extend over several Mb and we therefore included wild derived
inbred strains that may not share the same ancestral haplotypes in
order to achieve the greatest mapping resolution.
To determine how far out meaningful LD extended from highly
significant SNPs, we first calculated the r2s between the top SNPs
and every other marker in the genome. The r2s were then ranked
and the meaningful LD threshold was defined as being ranked in
the one percentile. The ranking and threshold calculation was
done separately for each of the top markers and showed that each
marker has a different distribution of r2 across the genome.
Therefore the threshold r2 for each marker was also different.
Other rank thresholds were examined but the 0.01 level seemed to
be the most useful in relation to the expected decay of LD as a
function of physical distance. Physically nearby (,5 megabases)
markers above the 0.01 rank threshold were considered to be in
real LD and not imperfect mirrors (see below). Finally, in regions
surrounding multiple associated SNPs, all marker to marker r2s
were calculated.
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In addition to LD caused by the presence of common
haplotypes, there is the phenomenon of markers sharing the same
or highly similar pattern of genotypes across strains but that may
be on different chromosomes. These ‘mirrors’ can occur by chance
and the phenomenon is aggravated by the non-random mating
history of the common inbred strains. These mirrors are
characterized by r2 values close or equal to 1. The problem is
that mirrors will give very similar association results making it
difficult to identify the exact location of the QTL. Distinguishing
between meaningful LD between physically related markers
caused by shared haplotypes versus mirror effect is challenging.
However, we used the following procedure based on the
parsimony principle to address this issue. After completing the in
silico scan and controlling the FDR at the 0.045 level, all pairwise
marker-to-marker r2s for the significant SNPs were calculated. To
determine the origin or the source of the true signal of a set of
mirrors, the mirrors were first physically mapped and then the
various solutions with different origins were plotted. The plot with
the fewest number of origins was determined to be the most
parsimonious.
Supporting Information
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discovery rate of 5%.
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